title: Acetylcholine/dopamine interaction in planaria.
abstract: Planaria represents the most primitive example of centralization and cephalization of nervous system. Previous reports indicate that planaria shows specific behavioral patterns, analogous to mammalian stereotypes, in response to drugs acting on acetylcholine or dopamine transmission. Here we further characterized these responses, and investigated the interactions between cholinergic and dopaminergic systems by means of behavioral methods. Exposure to cholinergic agonists physostigmine or nicotine produced hypokinesia with 'bridge-like' and 'walnut' positions, respectively. Blockade of muscarinic receptors by atropine produced 'screw-like' hyperkinesia. Exposure to dopamine agonists (nomifensine, apomorphine) produced marked hyperkinesia with 'screw-like' movements. Finally, exposure to dopamine antagonists produced immobility or 'bridge-like' position. Pre-exposure to physostigmine blocked the behavioral effects of nomifensine and reduced and markedly delayed the behavioral effects of apomorphine. Pre-exposure to apomorphine slightly reduced and delayed the behavioral changes by physostigmine. Finally, planaria exposed to atropine after either SCH23388 or sulpiride showed 'C-like' or 'screw-like' hyperkinesia, respectively. Thus, reduction of cholinergic transmission seems to play a pivotal role in determining hyperkinesia in planaria. Under these conditions, different patterns of hyperkinetic activities occur, according to the subpopulation of dopamine receptors stimulated by drugs. These findings suggest that interactions between cholinergic and dopaminergic systems occur very early in animal phylogeny.
authors.affiliation: Dipartimento di Scienze Neurologiche, Università 'La Sapienza', Viale dell'Università, 30 (box no. 41), 00185 Rome, Italy.
authors.forename: F R
authors.initials: FR
authors.lastname: Buttarelli
authors.forename: F E
authors.initials: FE
authors.lastname: Pontieri
authors.forename: V
authors.initials: V
authors.lastname: Margotta
authors.forename: G
authors.initials: G
authors.lastname: Palladini
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000818:Animals; D004298:Dopamine / Q000494:pharmacology*; D018491:Dopamine Agonists / Q000494:pharmacology; D018492:Dopamine Antagonists / Q000494:pharmacology; D006948:Hyperkinesis / Q000139:chemically induced / Q000662:veterinary*; D009068:Movement; D009424:Nervous System Physiological Phenomena; D010802:Phylogeny; D010932:Planarians / Q000502:physiology*; D011954:Receptors, Dopamine / Q000502:physiology*
chemical_list: D018491:Dopamine Agonists; D018492:Dopamine Antagonists; D011954:Receptors, Dopamine; D000109:Acetylcholine; D004298:Dopamine